Drug serialization regulations are now enforced across every major pharmaceutical market. The US Drug Supply Chain Security Act (DSCSA), EU Falsified Medicines Directive (FMD), and similar regulations in India, China, Brazil, and other markets require pharmaceutical manufacturers to assign unique serial numbers to individual saleable units, aggregate them into shipment hierarchies, and exchange transaction data across the supply chain. This whitepaper provides a comprehensive implementation roadmap for organizations at any stage of their serialization journey.
Pharmaceutical serialization is no longer optional in any major market. The convergence of patient safety concerns, counterfeit drug proliferation, and regulatory evolution has created a global mandate for unit-level product identification and traceability throughout the pharmaceutical supply chain. Organizations that have not yet achieved compliance face market access restrictions, financial penalties, and reputational damage.
The US Drug Supply Chain Security Act (DSCSA) represents the most comprehensive serialization mandate, requiring pharmaceutical manufacturers, wholesale distributors, dispensers, and repackagers to participate in an interoperable, electronic system to identify and trace prescription drugs distributed in the United States. Full enforcement of the enhanced drug distribution security requirements is now in effect.
Drug serialization touches every layer of your technology stack, from packaging line hardware through enterprise systems to inter-company data exchange. The architectural decisions you make at the outset of your program will determine its scalability, maintenance burden, and total cost of ownership for the next decade.
The foundation phase establishes the program governance, regulatory requirements baseline, and high-level architecture that will guide all subsequent phases. Rushing through this phase to begin packaging line integration is a common and costly mistake.
Enter your email to download the complete drug serialization implementation roadmap: achieving track-and-trace compliance with all frameworks, templates, and actionable insights.
A strategic whitepaper on implementing drug serialization and track-and-trace systems in compliance with DSCSA, EU FMD, and other global serialization mandates. Covers architecture, vendor selection, packaging line integration, and data management.
No spam. Unsubscribe anytime.
Our team can help you put these insights into action. Get a personalized consultation.
Talk to an Expert